• Arthritis

    Inflammation of one or more joints, causing pain and stiffness that can worsen with age.

    Nuclear factor kappa B is the master controller of inflammation at cellular level

    "Salsalate reduces inflammation"

  • DIABETES Mellitus

    Chronic inflammation results in pancreatic dysfunction, leading to Diabetes Mellitus

    Salsalate reduces HbA1C

  • Operative analgesia

    Narcotic pain management in postoperative patients leads to addiction

    Salsalate = Opioid sparing

  • Traumatic brain injury

    Life after brain injury

    "I" am not the same "me"

    Salsalate proven effective in animal model of TBI

  • Alzheimer's disease and dementia

    Its hard to cure Dementia. Lets still be hopeful!

    Salsalate proven effective in animal model of AD

Product Pipeline

RH Nanopharma has developed and continues to develop new formulations of salsalate:

  • Oral tablets, capsules, and soft gel caps of immediate release salsalate
  • Liquid formulation of immediate release salsalate
  • Nanosupsensions of salsalate for Intravenous use in reducing operative pain
  • Topical gels for soft tissue injury/pain using nanoparticles of salsalate
  • Ocular nanosuspensions for Dry Eye Disease (DED)
  • Nanosupension of oral salsalate for immediate relief of pain (Pre-IND Meeting successful - June 2018, IND submission in progress)

Future of Nanomedicine

Industry trend &
growth

Our Mission

RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases.

News and Events

RH Nanopharmacuticals Announces that U.S. FDA granted Pre-Investigational New Drug Meeting (Pre-IND) for Salsalate to be held on June 28, 2018

More info...